These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 31549998)

  • 1. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
    Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
    Raue F; Frank-Raue K
    Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning.
    He T; Shi S; Liu Y; Zhu L; Wei Y; Zhang F; Shi H; He Y; Han A
    BMC Cancer; 2024 Aug; 24(1):1069. PubMed ID: 39210289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
    Hirokawa M; Higuchi M; Suzuki A; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2020 Oct; 67(10):1071-1075. PubMed ID: 32595200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing incidence of thyroid cancer.
    Kitahara CM; Sosa JA
    Nat Rev Endocrinol; 2016 Nov; 12(11):646-653. PubMed ID: 27418023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.
    Ahtiainen V; Vaalavirta L; Tenhunen M; Joensuu H; Mäenpää H
    Acta Oncol; 2020 Sep; 59(9):1064-1071. PubMed ID: 32603613
    [No Abstract]   [Full Text] [Related]  

  • 9. Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
    Hanley JP; Jackson E; Morrissey LA; Rizzo DM; Sprague BL; Sarkar IN; Carr FE
    Thyroid; 2015 Jul; 25(7):812-22. PubMed ID: 25936441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
    Bauer AJ
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):589-611. PubMed ID: 33153669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
    Oh CM; Lim J; Jung YS; Kim Y; Jung KW; Hong S; Won YJ
    Cancer Med; 2021 Jun; 10(12):4087-4096. PubMed ID: 33979040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
    Rossi ED; Faquin WC; Pantanowitz L
    Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
    Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma.
    Alam IS; Patel KN
    Surg Clin North Am; 2024 Aug; 104(4):751-765. PubMed ID: 38944496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients.
    Johar J; Britton H; Wiseman SM
    Can J Surg; 2020 Feb; 63(1):E69-E70. PubMed ID: 32031767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort.
    Chung R; Guan H; Ponchiardi C; Cerda S; Marwaha N; Yilmaz OH; Pinjic E; McAneny D; Lee SL; Drake FT
    Thyroid; 2021 Jan; 31(1):68-75. PubMed ID: 32539676
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
    Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
    [No Abstract]   [Full Text] [Related]  

  • 19. Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions.
    Bauer AJ
    Semin Pediatr Surg; 2020 Jun; 29(3):150920. PubMed ID: 32571505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
    Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
    Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.